The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...

Medically reviewed by Robert Burakoff, MD Irritable bowel syndrome (IBS) is a combination of digestive symptoms, including ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

diff, but its first attempt missed the mark in a phase 3 trial and it is now advancing an updated formulation through mid-stage clinical testing. In the phase 3 ECOSPOR trial, patients who took ...

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

The UN Food and Agriculture Organization (FAO) has issued a call for data and experts relating to parasites in food.

Tests broaden access to accurate, easy-to-use diagnostics for patients in a decentralised setting Roche has been granted US ...

cobas HSV 1 and 2 Test, cobas C.diff Test, cobas CT/NG Test (chlamydia/gonorrhea), cobas HPV Test, cobas BRAF V600 Mutation Test, cobas EGFR Mutation Test, and the cobas KRAS Mutation Test.

The US Centers for Disease Control and Prevention (CDC) today confirmed another human H5N1 avian flu case in California, which likely reflects follow-up testing of a presumed positive involving a San ...